Biopharma Co. Signs Exclusive License Deal for Ricin Antigen
Source: Streetwise Reports  (7/27/22)
Shares of Soligenix Inc. traded 8% higher after the company reported it formed a strategic global partnership to supply SERB Pharmaceuticals with its novel ricin antigen for use in developing a therapeutic treatment against ricin poisoning. More >

Biomedical Firms Merger Makes Programming Cells Easier
Source: Streetwise Reports  (7/26/22)
Shares of Zymergen Inc. traded 16% higher after the company reported it agreed to be acquired by Ginkgo Bioworks Inc. in an all-stock transaction valued at $300 million. More >

Cancer Co.'s Price Target Adjusted After Reverse Stock Split
  (7/25/22)
Late clinical-stage biopharmaceutical company Cellectar Biosciences Inc. very recently underwent a one for 10 reverse stock split. ROTH Capital Partners LLC advised that it has adjusted its forward projections for the firm and adjusted its 12-month price target to $40/share. More >

Franco and Royal Make Major Investments
Source: Adrian Day  (7/25/22)
Expert Adrian Day discusses recent purchases from two royalty companies, as well as preliminary quarterly reports from several gold companies that he considers top buys right now. More >

Radiotherapy Co. On-Track With Two Clinical Trials
  (7/24/22)
Plus Therapeutics Inc. is developing novel radiotherapy treatments for several rare cancer targets including glioblastoma and leptomeningeal metastases. H.C. Wainwright & Co. advised in a research note that it is reiterating its Buy rating on the company as it expects that upcoming data from two key trials for the firm's RNL-based treatments could provide a major catalyst for the stock in H2/22. More >

Pro Athlete Benefits From Co.'s Wound Treatment Device
Source: Streetwise Reports  (7/22/22)
Shares of SANUWAVE Health Inc. traded 12% higher after the company reported it successfully treated legendary football player Jim McMahon Jr. with its ENERGY FIRST system. More >

Medical Device Firm Maintains Growth Momentum in Q2/22
  (7/21/22)
electroCore Inc.'s Q2/22 and H1/22 revenues are up quarter over quarter and year over year, respectively, and the upward trend is expected to continue through year-end 2022, noted an H.C. Wainwright & Co. report. More >

Amazon Makes $3.9B Bid for Virtual Primary Care Co.
Source: Streetwise Reports  (7/21/22)
Shares of One Medical traded nearly 70% higher after the company reported it agreed to be acquired by Amazon Inc. for $18.00 per share in an all-cash deal valued at $3.9 billion. More >

Biotech Co.'s Phase 3 Trial First to Get Grant
Source: Streetwise Reports  (7/20/22)
A revenue-generating junior biotech company based in the U.K. has become the first public company to be approved for a government grant to fund most of a Phase 3 study exploring the use of psychedelics to treat alcohol use disorder. It could be a catalyst for the share price. More >

Drug Repurposing Co. Provides Opportunity for High Rewards
  (7/20/22)
Vancouver-based pharmaceutical development firm Algernon Pharmaceuticals Inc. recently reported topline data from a Phase 2a trial of ifenprodil in IPF patients with chronic cough that met its endpoint and demonstrated promising initial efficacy. Research Capital Corp. advised that it is maintaining its CA$25.00/share price target and "Speculative Buy" rating on the company. More >

Expert Says the Tide Has Gone Out
Source: Michael J. Ballanger  (7/20/22)
Expert Michael Ballanger reviews the current market cycle, Elon Musk's impact on the stock market, and reveals the stock he says has a positive outlook amidst the chaotic backdrop of summer 2022. More >

Mining Co. Forms JV to Manage Key NewRange Materials Assets
Source: Streetwise Reports  (7/20/22)
PolyMet Mining Corp. shares traded nearly 8% higher after the company reported it entered into a joint-venture deal with Teck Resources Ltd. to develop copper, nickel, cobalt, and platinum group metals resources at the NorthMet and Mesaba properties in Minnesota. More >

Trial Results Show New Drug Improves Dry Eye Symptoms
Source: Matthew Caufield   (7/19/22)
These study data from Aldeyra Therapeutics Inc. solidified the therapeutic's path to filing a new drug application, potentially in Q3/22, noted an H.C. Wainwright & Co. report. More >

Uranium Co. Reports Solid Drill Results at Alligator River
Source: Streetwise Reports  (7/19/22)
Shares of Vimy Resources Ltd. traded 19% higher after the company reported positive results from the first two diamond drill holes at its Alligator River Project in Australia's Northern Territory. The company said it plans to prepare a mineral resource update for its Angularli Deposit in late 2022. More >

Tectonic Metals Closes CA$2.3M Private Placement
Source: The Critical Investor  (7/19/22)
The Critical Investor explains why major shareholders like Crescat Capital "are stepping up once again ... but this time increasing their ownership in Tectonic even more" as everyone eagerly awaits the results from Seventymile.
More >

Satellite Co. Posts Record Revenue in Q2 From Aerospace Firm
Source: Streetwise Reports  (7/19/22)
Shares of Sidus Space Inc. traded 37% higher after the satellite technology company reported it has expanded the scope of its working relationship and increased deliverables to Teledyne Technologies Inc. Sidus stated that revenues registered under its contracts with Teledyne in Q2/22 were the highest amounts earned over the course of its four-year relationship with that company. More >

Biopharma Co. Looks to Expand New Drug Label Down the Road
  (7/18/22)
ScPharmaceuticals Inc. just released topline results from a Phase 2 pilot study supporting the drug developer that is pursuing the expansion of its new drug label, noted an H.C. Wainwright & Co. report. More >

LIT Lithium Discovery Could Light Up Share Price
Source: Streetwise Reports  (7/18/22)
Lithium carbonate prices are up 340% year-over-year and one lithium junior explorer operating in Argentina just drilled some healthy lithium grades in a salar that extends beyond its property boundary and onto the junior's concessions. More >

Canada Firm Holds Promising Assets in 'Lithium Triangle'
Source: Streetwise Reports  (7/18/22)
Fundamental Research Corp. mentioned in a research note that this company is on a clear path to a potential new discovery in Argentina. The firm stated that it expects that a maiden resource estimate for its properties will be completed next year and is initiating coverage with a "Buy" rating. More >

Renewed Advance Imminent as Banks Create More Cash to Shore Up Debt
Source: Clive Maund  (7/18/22)
Expert Clive Maund examines the confluence of increasing debt and the precious metals sector and speculates on how the European Central Bank's plan to engage in "unlimited bond buying" will impact the market. More >

Junior 'Swings for Fences' in Golden Triangle
Source: Streetwise Reports  (7/15/22)
StrikePoint Gold Inc. is "laser-focused" on its Porter Idaho and Willoughby properties in British Columbia's Golden Triangle. More >

Healthcare Co.’s Psychedelic-Assisted Treatments Have ‘Blockbuster Drug Potential’
Source: Patrick Trucchio  (7/15/22)
Psychedelic-assisted therapy has shown in a clinical trial that it can help patients with alcohol use disorder (AUD) or alcoholism. One company hopes to bring its treatments to clinics throughout Europe and become the go-to standard of care for AUD. More >

Pharma Co. Reduces Mortality Rates by 70% in ALS Trial
Source: Streetwise Reports  (7/15/22)
Shares of Clene Inc. traded 38% higher yesterday after the company reported that its CNM-Au8 was shown to significantly decrease mortality in its RESCUE-ALS long-term extension trial. More >

eVTOL Aircraft Firm Secures Deal With Major US Airline
Source: Streetwise Reports  (7/15/22)
Vertical Aerospace Ltd.'s shares traded 70% higher after the eVTOL aircraft designer and manufacturer reported it secured a pre-delivery payment commitment from American Airlines Group for the first 50 units of its VX4 eVTOL aircraft. The firm also advised it received a separate order for 50 VX4s from a business jet operator in Belgium. More >

Healthcare Co. Wants Share of $17.5B Addiction Treatment Industry
Source: Jason McCarthy  (7/14/22)
One healthcare co. is currently rated a Buy and is making a push for a share of the $17.5-billion addiction treatment industry after a recent study showed its psychedelic-assisted psychotherapy treatment showed a significant decrease in alcohol use, noted a Maxim Group equity research report. More >